LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Erratum to A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma

Photo by ang10ze from unsplash

[This corrects the article DOI: 10.1177/1758835919889001.]. Click to show full abstract

[This corrects the article DOI: 10.1177/1758835919889001.].

Keywords: efficacy safety; safety met; study efficacy; erratum phase; phase study; met inhibitor

Journal Title: Therapeutic Advances in Medical Oncology
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended


                Click one of the above tabs to view related content.